Menopause and Memory Loss with Estrigenix - Ep. 208

FemTech Focus

English - May 10, 2023 04:00 - 56 minutes - 51.4 MB - ★★★★★ - 51 ratings
Education Technology femtech health tech wellness womenshealth Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Heavy Menstrual Bleeding with Bayer - Ep. 207

Next Episode: FemTech in India with Gytree - Ep. 209

In this episode, we talk to Dr. Karyn Frick, Distinguished Professor of Psychology at the University of Wisconsin-Milwaukee and co-founder and Chief Scientific Officer of Estrigenix Therapeutics. In this episode, we discuss Types of memory loss in humans, the relationship between estrogen and the brain and the link between hot flashes and dementia. This is a great opportunity to learn more about the science behind menopause and memory loss.

Remember to like, rate and subscribe and enjoy the episode!

Guest bio

Dr. Karyn Frick is Distinguished Professor of Psychology at the University of Wisconsin-Milwaukee and a co-founder and the Chief Scientific Officer of Estrigenix Therapeutics, Inc. She has nearly 30 years of experience studying the neurobiological mechanisms underlying memory formation, with a particular focus on the cellular and molecular mechanisms through which estrogens regulate memory, hot flashes, and mood. She has published >110 articles and book chapters and edited the 2020 book "Estrogens and Memory: Basic Research and Clinical Implications” (Oxford University Press). Dr. Frick is a fellow of the American Psychological Association and Association for Psychological Science, and has been awarded the Society for Women’s Health Research/Medtronic Prize for Scientific Contributions to Women’s Health.

Organization bio

Estrigenix's mission is to develop drugs, based on our platform technology and expertise in estrogen biology, that can help women live healthier and longer lives. We aim to dramatically improve women’s health by developing safe, clinically proven treatments for the physical and mental effects of menopause. We are developing compounds to reduce menopause symptoms like hot flashes and memory dysfunction without the adverse health risks associated with traditional estrogen therapies. Because there is a correlation hot flash severity in the 50s and increased risk of dementia in the 60s and beyond, safe treatments for hot flashes may also alleviate women's increased risk of Alzheimer’s disease.

FemTech Focus Podcast bio

The FemTech Focus Podcast is brought to you by FemHealth Insights, the leader in Women’s Health market research and consulting. In this show, Dr. Brittany Barreto hosts meaningfully provocative conversations that bring FemTech experts - including doctors, scientists, inventors, and founders - on air to talk about the innovative technology, services, and products (collectively known as FemTech) that are improving women's health and wellness. Though many leaders in FemTech are women, this podcast is not specifically about female founders, nor is it geared toward a specifically female audience. The podcast gives our host, Dr. Brittany Barreto, and guests an engaging, friendly environment to learn about the past, present, and future of women’s health and wellness.

FemHealth Insights bio

Led by a team of analysts and advisors who specialize in female health, FemHealth Insights is a female health-specific market research and analysis firm, offering businesses in diverse industries unparalleled access to the comprehensive data and insights needed to illuminate areas of untapped potential in the nuanced women’s health market.

Time Stamps

[03:52] Dr. Frick’s background

[06:33] Measuring memory in rats and mice

[10:27] Do rats and mice go through menopause?

[11:50] Context of memory loss in humans

[19:00] Scientific history of estrogen and the brain

[23:07] Can we see memory changes in human women throughout the menstrual cycle?

[25:29] Contraception and memory

[28:44] Why has dementia previously not been researched very well?

[33:35] What is estrogen telling a cell?

[36:55] Funding this research

[41:42] Estrigenix